「知の失敗」としての薬害を考えるための覚え書 : 「イレッサ」報道記事「『夢の抗がん剤』落とし穴」に落とし穴はないか A Note for Considering Anticancer Drug-induced Death as "Failure of Knowledge" : A Newspaper Article titled "Iressa, Drug of a Dream, have Pitfalls" have Pitfalls

この論文にアクセスする

この論文をさがす

抄録

Since Oct.15^<th>, 2002, newspapers have reported a number of deaths related to the adverse reaction to anti-lung cancer drug, "Irresa"(generic name: gefitinib, Asterazeneca). The reports described this drug-induced disaster as a result of irresponsibility of Japanese government, pharmaceutical company and medical professionals. However before the Oct.15-article, the newspapers had covered Irresa as a notable drug that has molecular targeting action pinpointing cancer growth mechanism. For a critical analysis of this new drug, more of the clinical evidence is needed than pharmacological mechanism. And yet pharmacological knowledge based analogy and metaphor is often used in clinical doctors' stories or narratives. And mass media make report without critically examining the medical knowledge. I would like to argue this drug-induced disaster as "failure of knowledge".

収録刊行物

  • 青森公立大学紀要

    青森公立大学紀要 9(1), 47-61, 2003-09-30

    青森公立大学

各種コード

  • NII論文ID(NAID)
    110002558626
  • NII書誌ID(NCID)
    AN10521710
  • 本文言語コード
    JPN
  • 雑誌種別
    大学紀要
  • ISSN
    13419412
  • NDL 記事登録ID
    6732535
  • NDL 雑誌分類
    ZV1(一般学術誌--一般学術誌・大学紀要)
  • NDL 請求記号
    Z22-B183
  • データ提供元
    NDL  NII-ELS 
ページトップへ